Protective effect of peroxisome proliferator activator receptor (PPAR)-α and -γ ligands against methotrexate-induced nephrotoxicity

References

• Schmiegelow K. Advances in individual prediction of methotrexate toxicity: a review. Br J Haematol 2009;146:489–503
   PubMed Web of Science ®Google Scholar
• Messmann R, Allegra C. Antifolates. In: Chabner B, Longo D, eds. Cancer chemotherapy and biotherapy. Philadelphia: Lippincott Williams & Wilkins; 2001:139–184
   Google Scholar
• Vardi N, Parlakpinar H, Ates B, et al. The protective effects of Prunus armeniaca L (apricot) against methotrexate-induced oxidative damage and apoptosis in rat kidney. J Physiol Biochem 2013;69:371–381
   PubMed Web of Science ®Google Scholar
• Cağlar Y, Ozgür H, Matur I, et al. Ultrastructural evaluation of the effect of N-acetylcysteine on methotrexate nephrotoxicity in rats. Histol Histopathol 2013;28:865–874
   PubMed Web of Science ®Google Scholar
• Guan Y, Breyer MD. Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease. Kidney Int 2001;60:14–30
   PubMed Web of Science ®Google Scholar
• Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990;347:645–650
   PubMed Web of Science ®Google Scholar
• Dreyer C, Krey G, Keller H, et al. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell 1992;68:879–887
   PubMed Web of Science ®Google Scholar
• Zhou Y, Kong X, Zhao P, et al. Peroxisome proliferator-activated receptor-α is renoprotective in doxorubicin-induced glomerular injury. Kidney Int 2011;79:1302–1311
   PubMed Web of Science ®Google Scholar
• Jun M, Zhu B, Tonelli M, et al. Effects of fibrates in kidney disease: a systematic review and meta-analysis. J Am Coll Cardiol 2012;60:2061–2071
   PubMed Web of Science ®Google Scholar
• Cheng CF, Chen HH, Lin H. Role of PPARα and its agonist in renal diseases. PPAR Res 2010;2010:345098 . doi: 10.1155/2010/345098
   PubMedGoogle Scholar
• Iglesias P, Díez JJ. Peroxisome proliferator-activated receptors agonists in renal disease. Euro J Endocrinol 2006;154:613–621
   PubMed Web of Science ®Google Scholar
• Gelosa P, Banfi C, Gianella A, et al. Peroxisome proliferator-activated receptor. Agonism prevents renal damage and the oxidative stress and inflammatory processes affecting the brains of stroke-prone rats. J Pharmacol Exp Ther 2010;335:324–331
   PubMed Web of Science ®Google Scholar
• Pereira MG, Câmara NO, Campaholle G, et al. Pioglitazone limits cyclosporine nephrotoxicity in rats. Int Immunopharmacol 2006;6:1943–1951
   PubMed Web of Science ®Google Scholar
• Asvadi I, Hajipour B, Asvadi A, et al. Protective effect of pentoxyfilline in renal toxicity after methotrexate administration. Eur Rev Med Pharmacol Sci 2011;15:1003–1009
   PubMed Web of Science ®Google Scholar
• El-Sheikh AA, Morsy MA, Mahmoud MM, et al. Effect of coenzyme-Q10 on doxorubicin-induced nephrotoxicity in rats. Adv Pharmacol Sci 2012;2012:981461 . doi: 10.1155/2012/981461
   PubMedGoogle Scholar
• Mihara M, Uchiyama M. Properties of thiobarbituric acid-reactive materials obtained from lipid peroxide and tissue homogenate. Chem Pharm Bull (Tokyo) 1983;31:605–611
   PubMed Web of Science ®Google Scholar
• Fendler C, Braun J. Use of methotrexate in inflammatory myopathies. Clin Exp Rheumatol 2010;28:S164–S167
   PubMed Web of Science ®Google Scholar
• Abraham P, Kolli VK, Rabi S. Melatonin attenuates methotrexate-induced oxidative stress and renal damage in rats. Cell Biochem Funct 2010;28:426–433
   PubMed Web of Science ®Google Scholar
• Uz E, Oktem F, Yilmaz HR, et al. The activities of purine-catabolizing enzymes and the level of nitric oxide in rat kidneys subjected to methotrexate: protective effect of caffeic acid phenethyl ester. Mol Cell Biochem 2005;277:165–170
   PubMed Web of Science ®Google Scholar
• Oktem F, Yilmaz HR, Ozguner F, et al. Methotrexate-induced renal oxidative stress in rats: the role of a novel antioxidant caffeic acid phenethyl ester. Toxicol Ind Health 2006;22:241–247
   PubMed Web of Science ®Google Scholar
• Kolli VK, Abraham P, Isaac B, Selvakumar D. Neutrophil infiltration and oxidative stress may play a critical role in methotrexate-induced renal damage. Chemotherapy 2009;55:83–90
   PubMed Web of Science ®Google Scholar
• Isshiki K, Haneda M, Koya D, et al. Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes 2000;49:1022–1032
   PubMed Web of Science ®Google Scholar
• Xu X, Chen P, Zheng Q, et al. Effect of pioglitazone on diabetic nephropathy and expression of HIF-1α and VEGF in the renal tissues of type 2 diabetic rats. Diabetes Res Clin Pract 2011;93:63–69
   PubMed Web of Science ®Google Scholar
• Ohga S, Shikata K, Yozai K, et al. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation. Am J Physiol Renal Physiol 2007;292:F1141–F1150
   PubMed Web of Science ®Google Scholar
• Jesse CR, Bortolatto CF, Wilhelm EA, et al. The peroxisome proliferator-activated receptor-γ agonist pioglitazone protects against cisplatin-induced renal damage in mice. J Appl Toxicol 2014;34:25–32
   Google Scholar
• Polvani S, Tarocchi M, Galli A. PPARγ and oxidative stress: Con(β) catenating NRF2 and FOXO. PPAR Res 2012;2012:641087 . doi: 10.1155/2012/641087
   PubMed Web of Science ®Google Scholar
• Balakumar P, Kadian S, Mahadevan N. Are PPAR alpha agonists a rational therapeutic strategy for preventing abnormalities of the diabetic kidney? Pharmacol Res 2012;65:430–436
   PubMed Web of Science ®Google Scholar
• Zak Z, Gelebart P, Lai R. Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFalpha/NF-KappaB signaling axis. Leukemia 2010;24:1476–1486
   PubMed Web of Science ®Google Scholar
• Belfort R, Berria R, Cornell J, Cusi K. Fenofibrate reduces systemic inflammation markers independent of its effects on lipid and glucose metabolism in patients with the metabolic syndrome. J Clin Endocrinol Metab 2010;95:829–836
   PubMed Web of Science ®Google Scholar
• Liu SN, Liu Q, Li LY, et al. Long-term fenofibrate treatment impaired glucose-stimulated insulin secretion and up-regulated pancreatic NF-Kappa B and iNOS expression in monosodium glutamate-induced obese rats: is that a latent disadvantage? J Transl Med 2011;9:176 . doi: 10.1186/1479-5876-9-176
   PubMed Web of Science ®Google Scholar
• Toblli JE, Cao G, Giani JF, et al. Antifibrotic effects of pioglitazone at low doses on the diabetic rat kidney are associated with the improvement of markers of cell turnover, tubular and endothelial integrity, and angiogenesis. Kidney Blood Press Res 2011;34:20–33
   PubMed Web of Science ®Google Scholar